Antibiotic compound
Details for Australian Patent Application No. 2004259014 (hide)
International Classifications
Event Publications
16 February 2006 PCT application entered the National Phase
PCT publication WO2005/009391 Priority application(s): WO2005/009391
17 December 2009 Application Accepted
Published as AU-B-2004259014
28 January 2010 Alteration of Name
The name of the applicant has been altered to Merck Sharp & Dohme de Espana, S.A.; Merck Sharp & Dohme Corp.
15 April 2010 Standard Patent Sealed
4 October 2012 Alteration of Name
The name of the patentee has been altered to Merck Sharp & Dohme de Espana, S.A.; Merck Sharp & Dohme Corp.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2004259019-Acellular tissue matrices made from galactose alpha-1,3-galactose-deficient tissue
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser